X0306 4 2022-03-09 0 0001036262 INTEST CORP INTT 0001821315 Grant Richard N. Jr. C/O INTEST CORP 804 EAST GATE DR, SUITE 200 MT. LAUREL NJ 08054 1 1 0 0 President & CEO Common Stock 2022-03-09 4 A 0 13664 0 A 173942 D Common Stock 2022-03-09 4 A 0 13662 0 A 187604 D Common Stock 2022-03-10 4 S 0 1167 9.5 D 186437 D Employee Stock Option (right to buy) 9.76 2022-03-09 4 A 0 25692 0 A 2032-03-08 Common Stock 25692 25692 D The shares acquired are restricted shares issued pursuant to the Issuer's Third Amended and Restated 2014 Stock Plan (the "Plan") and will vest 25% annually commencing on March 9, 2023. The shares acquired are performance-based restricted shares issued pursuant to the Plan and will vest on March 9, 2025 dependent upon certain performance criteria. The amount shown reflects the number of shares that will vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 20,493. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2021. The option was issued pursuant to the Plan and will vest 25% annually commencing on March 9, 2023. /s/ Richard N. Grant, Jr. 2022-03-11